Impact of ABO-Incompatible Listing on Wait-List Outcomes Among Infants Listed for Heart Transplantation in the United States | Zendy

Christopher S. Almond | Zendy; Kimberlee Gauvreau | Zendy; Ravi R. Thiagarajan | Zendy; Gary Piercey | Zendy; Elizabeth D. Blume | Zendy; Leslie Smoot | Zendy; Francis FynnThompson | Zendy; Tajinder P. Singh | Zendy

Open Access

Impact of ABO-Incompatible Listing on Wait-List Outcomes Among Infants Listed for Heart Transplantation in the United States

Author(s) -

Christopher S. Almond,

Kimberlee Gauvreau,

Ravi R. Thiagarajan,

Gary Piercey,

Elizabeth D. Blume,

Leslie Smoot,

Francis FynnThompson,

Tajinder P. Singh

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.885756

Subject(s) - medicine , abo blood group system , transplantation , heart transplantation , cohort , extracorporeal membrane oxygenation , retrospective cohort study , pediatrics , propensity score matching

The purported advantage of ABO-incompatible (ABO-I) listing is to reduce wait times and wait-list mortality among infants awaiting heart transplantation. We sought to describe recent trends in ABO-I listing for US infants and to determine the impact of ABO-I listing on wait times and wait-list mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research